Literature DB >> 18356403

Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

Leigh Perreault1, Yong Ma, Sam Dagogo-Jack, Edward Horton, David Marrero, Jill Crandall, Elizabeth Barrett-Connor.   

Abstract

OBJECTIVE: In participants of the Diabetes Prevention Program (DPP) randomized to intensive lifestyle modification (ILS), meeting ILS goals strongly correlated with prevention of diabetes in the group as a whole. Men met significantly more ILS goals than women but had a similar incidence of diabetes. Therefore, we explored sex differences in risk factors for diabetes and the effect of ILS on risk factors. RESEARCH DESIGN AND METHODS: Baseline risk factors for diabetes and percent change in risk factors over the first year in men versus women were compared using Wilcoxon's rank-sum tests.
RESULTS: At baseline, men were older and had a larger waist circumference; higher fasting plasma glucose concentration, caloric intake, and blood pressure; and lower HDL cholesterol and corrected insulin response than women, who were less physically active and had a higher BMI (P < 0.01 for all comparisons). Over the first year of the DPP, no sex difference in risk factors for diabetes was observed for those who lost <3% body weight. Weight loss of 3-7% body weight yielded greater decreases in 2-h glucose (P < 0.01), insulin concentration (P < 0.04), and insulin resistance (P < 0.03) in men than in women. Weight loss of >7% body weight resulted in greater decreases in 2-h glucose (P < 0.01), triglyceride level (P < 0.01), and A1C (P < 0.03) in men than in women.
CONCLUSIONS: Weight loss >3% body weight yielded greater reduction in risk factors for diabetes in men than in women. Despite the more favorable effects of ILS in men, baseline risk factors were more numerous in men and likely obscured any sex difference in incident diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356403      PMCID: PMC2453677          DOI: 10.2337/dc07-2390

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  22 in total

1.  Effect of weight loss with lifestyle intervention on risk of diabetes.

Authors:  Richard F Hamman; Rena R Wing; Sharon L Edelstein; John M Lachin; George A Bray; Linda Delahanty; Mary Hoskin; Andrea M Kriska; Elizabeth J Mayer-Davis; Xavier Pi-Sunyer; Judith Regensteiner; Beth Venditti; Judith Wylie-Rosett
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

2.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Authors:  H C Gerstein; S Yusuf; J Bosch; J Pogue; P Sheridan; N Dinccag; M Hanefeld; B Hoogwerf; M Laakso; V Mohan; J Shaw; B Zinman; R R Holman
Journal:  Lancet       Date:  2006-09-23       Impact factor: 79.321

3.  The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

Review 4.  Gender differences in substrate metabolism during endurance exercise.

Authors:  M A Tarnopolsky
Journal:  Can J Appl Physiol       Date:  2000-08

5.  Beneficial associations of physical activity with 2-h but not fasting blood glucose in Australian adults: the AusDiab study.

Authors:  Genevieve N Healy; David W Dunstan; Jonathan E Shaw; Paul Z Zimmet; Neville Owen
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

6.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.

Authors:  S L Edelstein; W C Knowler; R P Bain; R Andres; E L Barrett-Connor; G K Dowse; S M Haffner; D J Pettitt; J D Sorkin; D C Muller; V R Collins; R F Hamman
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

8.  Mortality trends in men and women with diabetes, 1971 to 2000.

Authors:  Edward W Gregg; Qiuping Gu; Yiling J Cheng; K M Venkat Narayan; Catherine C Cowie
Journal:  Ann Intern Med       Date:  2007-06-18       Impact factor: 25.391

9.  Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion.

Authors:  D I Phillips; P M Clark; C N Hales; C Osmond
Journal:  Diabet Med       Date:  1994-04       Impact factor: 4.359

10.  Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study.

Authors:  B V Howard; L D Cowan; O Go; T K Welty; D C Robbins; E T Lee
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

View more
  49 in total

1.  Plasma lipid levels predict dysglycemia in a biracial cohort of nondiabetic subjects: Potential mechanisms.

Authors:  Ibiye Owei; Nkiru Umekwe; Jim Wan; Samuel Dagogo-Jack
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-17

2.  Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.

Authors:  Rena R Wing
Journal:  Arch Intern Med       Date:  2010-09-27

Review 3.  Primary and secondary prevention of ischemic heart disease in women.

Authors:  Priya Kohli
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

4.  Health status, perceptions and needs of Hispanics in rural Shelbyville, Kentucky.

Authors:  Irma N Ramos; Savitri N Appana; Guy Brock; Ted Kalbfleisch; Qiang He; Kenneth S Ramos
Journal:  J Immigr Minor Health       Date:  2015-02

Review 5.  Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Gabriel Gimenez-Perez; Didac Mauricio; Marta Roqué I Figuls; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2017-12-04

6.  Outcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino Diabetes Prevention Project.

Authors:  Ira S Ockene; Trinidad L Tellez; Milagros C Rosal; George W Reed; John Mordes; Philip A Merriam; Barbara C Olendzki; Garry Handelman; Robert Nicolosi; Yunsheng Ma
Journal:  Am J Public Health       Date:  2011-12-15       Impact factor: 9.308

7.  Variations in the GST activity are associated with single and combinations of GST genotypes in both male and female diabetic patients.

Authors:  Durga Koteswara Rao; Noor Ahmad Shaik; Ahmad Imran; Dwarakanath K Murthy; Eswar Ganti; Chitralekha Chinta; Hanmantha Rao; Nazia Sultana Shaik; Jumana Yousuf Al-Aama
Journal:  Mol Biol Rep       Date:  2014-01-01       Impact factor: 2.316

8.  ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Authors:  Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-04       Impact factor: 4.310

9.  Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy.

Authors:  David J Decewicz; David M Neatrour; Amy Burke; Mary Jane Haberkorn; Heather L Patney; Marina N Vernalis; Darrell L Ellsworth
Journal:  Lipids Health Dis       Date:  2009-06-29       Impact factor: 3.876

10.  Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D).

Authors:  Timo Saaristo; Leena Moilanen; Eeva Korpi-Hyövälti; Mauno Vanhala; Juha Saltevo; Leo Niskanen; Jari Jokelainen; Markku Peltonen; Heikki Oksa; Jaakko Tuomilehto; Matti Uusitupa; Sirkka Keinänen-Kiukaanniemi
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.